BioXcel Therapeutics, Inc. (BTAI)
0.1866
-0.53
(-74.04%)
USD |
NASDAQ |
Aug 28, 16:00
0.1666
-0.02
(-10.72%)
After-Hours: 20:00
BioXcel Therapeutics Market Cap : 5.842M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 22.50M |
| August 26, 2026 | 24.42M |
| August 25, 2026 | 23.23M |
| August 24, 2026 | 23.81M |
| August 21, 2026 | 25.16M |
| August 20, 2026 | 25.00M |
| August 19, 2026 | 25.90M |
| August 18, 2026 | 24.80M |
| August 17, 2026 | 27.86M |
| August 14, 2026 | 37.25M |
| August 13, 2026 | 35.37M |
| August 12, 2026 | 33.18M |
| August 11, 2026 | 29.17M |
| August 10, 2026 | 25.12M |
| August 07, 2026 | 24.41M |
| August 06, 2026 | 22.48M |
| August 05, 2026 | 22.76M |
| August 04, 2026 | 23.30M |
| August 03, 2026 | 22.95M |
| July 31, 2026 | 21.88M |
| July 30, 2026 | 21.47M |
| July 29, 2026 | 21.72M |
| July 28, 2026 | 22.88M |
| July 27, 2026 | 23.47M |
| July 24, 2026 | 22.95M |
| Date | Value |
|---|---|
| July 23, 2026 | 23.56M |
| July 22, 2026 | 23.82M |
| July 21, 2026 | 24.30M |
| July 20, 2026 | 23.90M |
| July 17, 2026 | 24.03M |
| July 16, 2026 | 23.56M |
| July 15, 2026 | 24.95M |
| July 14, 2026 | 27.89M |
| July 13, 2026 | 23.89M |
| July 10, 2026 | 22.13M |
| July 09, 2026 | 22.68M |
| July 08, 2026 | 21.72M |
| July 07, 2026 | 28.16M |
| July 06, 2026 | 29.78M |
| July 02, 2026 | 37.36M |
| July 01, 2026 | 37.09M |
| June 30, 2026 | 38.18M |
| June 29, 2026 | 37.90M |
| June 26, 2026 | 35.47M |
| June 25, 2026 | 33.84M |
| June 24, 2026 | 35.47M |
| June 23, 2026 | 34.11M |
| June 22, 2026 | 35.20M |
| June 18, 2026 | 32.49M |
| June 17, 2026 | 32.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 233.72B |
| Anika Therapeutics, Inc. | 283.18M |
| BioCryst Pharmaceuticals, Inc. | 2.507B |
| Imunon, Inc. | 7.418M |
Market Cap Related Metrics
| PS Ratio | 5.047 |
| Price | 0.1866 |
| Earnings Yield | -2.27K% |